eNauka - pregled
Pregled prema Autor Weichenthal, Michael
Prikaz rezultata 1 do 5 od 5
| Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
|---|---|---|---|---|
| 2024 | Adjuvant Use of Pembrolizumab for Stage III Melanoma in a Real-World Setting in Europe | Weichenthal, Michael; ...; Kandolf, Lidija O; ...; (broj, koautora 22) | Naučni članak | 21M21 - Vodeći međunarodni časopis kategorije M21 |
| 2026 | BRAF/MEK inhibitor rechallenge in patients with non-resectable or metastatic BRAF V600-mutated melanoma: A stratified, controlled, retrospective EUMelaReg multicenter study | Weichenthal, Michael; ...; Popovic, Aleksandar; ...; (broj, koautora 31) | Naučni članak | Mp kategorija će biti prikazana naknadno. |
| 2022 | EMRseq: Registry-based outcome analysis on 1,000 patients with BRAF V600-mutated metastatic melanoma in Europe treated with either immune checkpoint or BRAF-/MEK inhibition. | Weichenthal, Michael; ...; Kandolf-Sekulovic, Lidija O; ...; (broj, koautora 20) | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2024 | Length of treatment after partial or complete remission in immunotherapy for metastatic melanoma: An EUMelaReg real world study | Asher, Nethanel; Mohr, Peter; Ellebaek, Eva; Bender, Marc; Mangana, Joanna; Kandolf, Lidija O; Gavrilova, Iva; Ascierto, Paolo Antonio; Gogas, Helen; Rutkowski, Piotr;
Schadendorf, Dirk; Bastholt, Lars; Weichenthal, Michael;
| Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2022 | Outcome of PD-1 inhibitor therapy of advanced melanoma patients according to demographic factors in a real-world setting across Europe | Weichenthal, Michael; ...; Kandolf-Sekulovic, Lidija O; ...; (broj, koautora 20) | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |